Skin tightening treatment for abdomen in women on GLP-1 medication
Part of Genetic & congenital, Skin clinical trials.
This study tests a treatment called poly-L-lactic acid to improve loose skin on the abdomen. It includes women who have been on a stable dose of GLP-1 medication for at least 6 months, as well as a small group who have never taken these drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 25 to 65.
- You have mild to moderate loose skin on your belly.
- Your weight has been stable for 3 months and your BMI is 27 or less.
- You are either currently taking a stable dose of a GLP-1 medication for at least 6 months, or you have never taken one.
- You are in good general health and willing to follow the study rules.
- If you could become pregnant, you must use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a skin serum to improve facial aging signs like fine lines and dullness. It is for post-menopausal women aged 45-65 who are taking a GLP-1 medication (e.g., Ozempic, Wegovy).
This study tests a topical serum to improve visible signs of facial aging in people who are currently taking a GLP-1 medication. If you qualify, you'll use the serum for the study period and see if it helps with fine lines, sagging, and skin texture.
This trial tests a radiofrequency microneedling device called Matrix Pro to lift droopy eyebrows and tighten loose skin under the chin and neck. It may help if you have mild to moderate skin laxity and are willing to avoid other cosmetic treatments during the study.
This study tests whether a hyaluronic acid filler (a common wrinkle-smoothing treatment) can improve skin quality in women who are taking GLP-1 medications for weight or diabetes. It aims to see if the filler can help with common skin changes like loss of firmness and wrinkles.
This study tests a laser procedure to improve visible skin looseness or scars. You may be eligible if you have a targeted skin area needing treatment and can follow scheduled visits and after-care.
This trial studies the safety of injectable biosimulators (PLLA and CAHA) used to treat loose skin or lost volume. It aims to see how these treatments interact with your body.
Hear when a new Laxity; Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.